News
PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel ...
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...
PharmAla Biotech (CSE:MDMA) issued a public warning after discovering that unknown parties are illegally marketing a nasal ...
PharmAla says its LaNeo MDMA drug products are exclusively available through a qualified practitioner’s prescription and ...
Choose from Biotech Logo stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Plans and pricing Video Back Videos home Signature collection ...
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...
Synthego, a Redwood City biotech company that raised millions but saw its debt costs become insurmountable, declared ...
Eikon Therapeutics, a Bay Area biotech startup with $1.1 billion in funding, is laying off dozens of employees and pointing ...
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results